کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2083419 1545336 2015 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Time lasting S-nitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی بیوتکنولوژی یا زیست‌فناوری
پیش نمایش صفحه اول مقاله
Time lasting S-nitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation
چکیده انگلیسی


• We encapsulated directly S-nitrosoglutathione (GSNO) within polymeric nanoparticles.
• The encapsulation efficiency was around 54% (m/m) containing 40 mM of GSNO.
• GSNO-NP released 100% of GSNO within 3 h in vitro in PBS.
• GSNO-NP delayed smooth muscle cells protein nitrosation from 1 h, free GSNO to 18 h.

Physiological S-nitrosothiols (RSNO), such as S-nitrosoglutathione (GSNO), can be used as nitric oxide (NO) donor for the treatment of vascular diseases. However, despite a half-life measured in hours, the stability of RSNO, limited by enzymatic and non-enzymatic degradations, is too low for clinical application. So, to provide a long-lasting effect and to deliver appropriate NO concentrations to target tissues, RSNO have to be protected. RSNO encapsulation is an interesting response to overcome degradation and provide protection. However, RSNO such as GSNO raise difficulties for encapsulation due to its hydrophilic nature and the instability of the S-NO bound during the formulation process. To our knowledge, the present study is the first description of the direct encapsulation of GSNO within polymeric nanoparticles (NP). The GSNO-loaded NP (GSNO-NP) formulated by a double emulsion process, presented a mean diameter of 289 ± 7 nm. They were positively charged (+40 mV) due to the methacrylic acid and ethylacrylate polymer (Eudragit® RL) used and encapsulated GSNO with a satisfactory efficiency (i.e. 54% or 40 mM GSNO loaded in the NP). In phosphate buffer (37 °C; pH 7.4), GSNO-NP released 100% of encapsulated GSNO within 3 h and remained stable still 6 h. However, in contact with smooth muscle cells, maximum protein nitrosation (a marker of NO bioavailability) was delayed from 1 h for free GSNO to 18 h for GSNO-NP. Therefore, protection and sustained release of NO were achieved by the association of a NO donor with a drug delivery system (such as polymeric NP), providing opportunities for vascular diseases treatment.

Figure optionsDownload high-quality image (149 K)Download as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Pharmaceutics and Biopharmaceutics - Volume 89, January 2015, Pages 1–8
نویسندگان
, , , , , , , ,